Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.

Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.

PLoS One. 2018 Oct 1;13(10):e0203941. doi: 10.1371/journal.pone.0203941. eCollection 2018.


Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens.

Cannatelli A, Principato S, Colavecchio OL, Pallecchi L, Rossolini GM.

Front Microbiol. 2018 Aug 7;9:1808. doi: 10.3389/fmicb.2018.01808. eCollection 2018.


Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit.

Avgoulea K, Di Pilato V, Zarkotou O, Sennati S, Politi L, Cannatelli A, Themeli-Digalaki K, Giani T, Tsakris A, Rossolini GM, Pournaras S.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e02457-17. doi: 10.1128/AAC.02457-17. Print 2018 Jul.


CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.

Crawford MA, Fisher DJ, Leung LM, Lomonaco S, Lascols C, Cannatelli A, Giani T, Rossolini GM, Doi Y, Goodlett DR, Allard MW, Sharma SK, Khan E, Ernst RK, Hughes MA.

MBio. 2017 Nov 14;8(6). pii: e01549-17. doi: 10.1128/mBio.01549-17.


A simple phenotypic method for screening of MCR-1-mediated colistin resistance.

Coppi M, Cannatelli A, Antonelli A, Baccani I, Di Pilato V, Sennati S, Giani T, Rossolini GM.

Clin Microbiol Infect. 2018 Feb;24(2):201.e1-201.e3. doi: 10.1016/j.cmi.2017.08.011. Epub 2017 Aug 19.


An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin.

Cannatelli A, Giani T, Aiezza N, Di Pilato V, Principe L, Luzzaro F, Galeotti CL, Rossolini GM.

Sci Rep. 2017 Jul 11;7(1):5071. doi: 10.1038/s41598-017-05167-6.


Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review.

Arena F, Henrici De Angelis L, D'Andrea MM, Cannatelli A, Fossati L, Di Pilato V, Giani T, Cavallo R, Rossolini GM.

Virulence. 2017 Nov 17;8(8):1900-1908. doi: 10.1080/21505594.2017.1286439. Epub 2017 Feb 23. Review. No abstract available.


Values of SP-A protein in the nasal mucosa.

Passali D, Astore S, Boccuzzi S, Loglisci M, Cannatelli A, Passali GC, Bellussi L.

HNO. 2016 Sep;64(9):671-5. doi: 10.1007/s00106-016-0190-2.


mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512.

Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, Giani T, Menichetti F, Rossolini GM.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5612-5. doi: 10.1128/AAC.01075-16. Print 2016 Sep.


Inhibitory activity of avibactam against selected ╬▓-lactamases expressed in an isogenic Escherichia coli strain.

Giani T, Cannatelli A, Di Pilato V, Testa R, Nichols WW, Rossolini GM.

Diagn Microbiol Infect Dis. 2016 Sep;86(1):83-5. doi: 10.1016/j.diagmicrobio.2016.03.002. Epub 2016 Mar 2.


First Detection of the mcr-1 Colistin Resistance Gene in Escherichia coli in Italy.

Cannatelli A, Giani T, Antonelli A, Principe L, Luzzaro F, Rossolini GM.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3257-8. doi: 10.1128/AAC.00246-16. Print 2016 May. No abstract available.


Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae.

Arena F, Henrici De Angelis L, Cannatelli A, Di Pilato V, Amorese M, D'Andrea MM, Giani T, Rossolini GM.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2509-12. doi: 10.1128/AAC.02981-15. Print 2016 Apr.


Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae.

Cannatelli A, Santos-Lopez A, Giani T, Gonzalez-Zorn B, Rossolini GM.

Antimicrob Agents Chemother. 2015 May;59(5):2898-900. doi: 10.1128/AAC.04998-14. Epub 2015 Feb 17.


MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.

Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM; COLGRIT Study Group.

Antimicrob Agents Chemother. 2014 Oct;58(10):5696-703. doi: 10.1128/AAC.03110-14. Epub 2014 Jul 14.


In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.

Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, D'Andrea MM, Rossolini GM.

Antimicrob Agents Chemother. 2014 Aug;58(8):4399-403. doi: 10.1128/AAC.02555-14. Epub 2014 May 19.


In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.

Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, Gaibani P, Rossolini GM.

Antimicrob Agents Chemother. 2013 Nov;57(11):5521-6. doi: 10.1128/AAC.01480-13. Epub 2013 Aug 26.

Supplemental Content

Loading ...
Support Center